CDKL5 deficiency disorder (CDD) is a rare neurodevelopmental condition characterized primarily by seizures and impairment of cognitive and motor skills. Additional phenotypes include microcephaly, dysmorphic facial features, and scoliosis. Mutations in cyclin-dependent kinase-like 5 (CDKL5) gene, encoding a kinase essential for normal brain development and function, are responsible for CDD. Zebrafish is an accepted biomedical model for the study of several genetic diseases and has many advantages over other models. Therefore, this work aimed to characterize the phenotypic, behavioral, and molecular consequences of the Cdkl5 protein disruption in a cdkl5 mutant zebrafish line (sa21938). cdkl5sa21938 mutants displayed a reduced head size, suggesting microcephaly, a feature frequently observed in CDD individuals. Double staining revealed shorter craniofacial cartilage structures and decrease bone mineralization in cdkl5 homozygous zebrafish indicating an abnormal craniofacial cartilage development and impaired skeletal development. Motor behavior analysis showed that cdkl5sa21938 embryos had less frequency of double coiling suggesting impaired glutamatergic neurotransmission. Locomotor behavior analysis revealed that homozygous embryos swim shorter distances, indicative of impaired motor activity which is one of the main traits of CCD. Although no apparent spontaneous seizures were observed in these models, upon treatment with pentylenetetrazole, seizure behavior and an increase in the distance travelled were observed. Quantitative PCR showed that neuronal markers, including glutamatergic genes were dysregulated in cdkl5sa21938 mutant embryos. In conclusion, homozygous cdkl5sa21938 zebrafish mimic several characteristics of CDD, thus validating them as a suitable animal model to better understand the physiopathology of this disorder.
CDKL5 deficiency disorder (CDD) is a rare X-linked neurodevelopmental condition characterized primarily by early-onset seizures, which generally begin in the first months of life and impairment of cognitive and motor skills (e.g., stereotypical hand movements, motor rigidity and deficient language acquisition)1,2. However, a variety of additional features have also been observed including microcephaly, scoliosis, bruxism, and distinctive facial features1,2. Despite the severity of the disease, the mechanisms responsible for its onset remain unclear.
The disorder is associated with a loss of cyclin-dependent kinase-like 5 (CDKL5) function due to a variety of mutations, but the link between the type or location of mutations and symptoms is not clearly understood3. Human CDLK5 is encoded by a single-copy gene located on the X chromosome and although the disorder is essentially observed in heterozygous females due to dominant X-linked mutations, the most severe phenotypes are observed in males2. CDKL5 is a ubiquitous protein mainly expressed in the brain, testes and thymus and found both in the cytoplasm and in the nucleus, where it co-localizes with nuclear speckles4. It has a kinase catalytic activity responsible for its autophosphorylation as well as the phosphorylation of amphiphysin 1, its first identified substrate5. CDKL5 can also mediate MeCP2 phosphorylation, suggesting a molecular link between CDKL5 disorder and MeCP2-associated Rett syndrome6. More recently, CDKL5 was shown to interact with Shootin1 and contribute to the regulation of neuronal polarization7.
Although mammalian models suggest a potential for reversibility, there are no approved therapies yet and standard treatments do not provide substantial symptom relief. The development of alternative and/or complementary model organisms that may accelerate the development of therapeutic approaches should therefore be contemplated to gain valuable insights in this field. The fact that the existing mouse models for Cdkl5 knockout (KO) do not completely reproduce the human CDKL5 phenotype makes the use of alternative models such as zebrafish mutant lines even more interesting. Indeed, as referred in a recent review, despite all the advantages of rodent models, none of the available mutant Cdkl5 mouse models develop early-onset seizures, a central feature of this syndrome in humans8. In contrast, it was recently shown that zebrafish, upon treatment with pentylenetetrazole (PTZ) can develop seizures, allowing researchers to investigate the molecular basis of this phenotype9.
Zebrafish is a suitable biomedical model that has been established as a genetically manipulable system10 and shares many physiological processes with humans including a large structural and functional conservation between zebrafish and human genes11. Zebrafish has a single cdkl5 gene and two alternative splice variants, similar to human CDKL5, were recently identified. Variant 1 is mainly expressed in the brain, while variant 2 is ubiquitously expressed12. Although the function and mode of action of Cdkl5 in fish have not been investigated, previous studies conducted in our laboratory showed that cdkl5 expression in zebrafish is in accordance with its known localization in humans13. Also, zebrafish cdkl5 structural organization, flanking genomic regions, and putative transcription factor binding sites located in its promoter region appear to be highly conserved when compared to its human ortholog13. The corresponding proteins also show a high degree of sequence conservation, particularly in the catalytic domains required for phosphorylation13. These data support the suitability of zebrafish as a valid model to investigate CDKL5 deficiency disorder.
The main objective of this study was to characterize a stable zebrafish model (cdkl5sa21938) expressing a mutant form of Cdkl5, in terms of their morphological and behavior phenotype as well as their molecular alterations. The overall goal is to provide a new model organism to further investigate the Cdkl5 signaling pathway and mechanisms that lead to CDKL5 deficiency disorder and ultimately, contribute to the identification of therapeutic targets to treat or relief symptoms of CDD.
Characterization of cdkl5 mutation present in the sa21938 stable zebrafish line
CDKL5 loss-of-function in humans is known to be responsible for the CDKL5 deficiency disorder phenotype. To investigate the effect of Cdkl5 loss-of-function, a mutant cdkl5 zebrafish line (sa21938) generated through the Zebrafish Mutation Project by ENU mutagenesis of males was characterized in this work.
Zebrafish cdkl5 has two splice variants encoding two proteins with 1039 and 1080 amino acids (aa), consisting of an N-terminal catalytic domain and a C-terminal region containing two nuclear localization signals and one nuclear export signal. cdkl5sa21938 mutants have a nonsense mutation in exon 11 of the cdkl5 gene (Fig. 1A) consisting of an alteration of cytosine by an adenine (Chr 11: 30,219,227 C > A) leading to the introduction of a premature termination codon. As a consequence, the mRNA could be susceptible to degradation by the nonsense-mediated mRNA decay (NMD) mechanism or result in the production of a truncated protein with 527 aa, lacking one of the nuclear localization signals and the nuclear exportation signal located in the C-terminus (Fig. 1B). If produced, the truncated protein is likely mislocalized in the cell.
Morphological characterization of cdkl5 sa21938 mutant zebrafish
The zebrafish obtained from EZRC European Zebrafish Resource Center (EZRC; www.ezrc.kit.edu) were genotyped to find heterozygous cdkl5sa21938 mutants and then in-crossed to obtain homozygous zebrafish. Sequencing results confirmed the existence of the three possible resulting genotypes (Fig. 2A). It was not possible to confirm the decrease of Cdkl5 protein levels by western blotting in these mutants due to the lack of specificity of the human anti-CDKL5 antibody to recognize the protein in zebrafish.
The phenotype regarding morphological features of the heterozygous (cdkl5+/−) and homozygous (cdkl5−/−) mutants were characterized throughout the first days of development. No severe morphological defects were observed in the mutants compared to wild-type embryos during the initial stages of development (Fig. 2B). Several morphometric parameters were analyzed in 5 dpf mutant and wild-type embryos (Fig. 2C). cdkl5 mutant embryos have a smaller total body length compared to wild-type embryos. Both heterozygous and homozygous embryos display a significantly reduced head length, anterior head width and posterior head width than wild-type embryos, being more prominent in the cdkl5−/− embryos.
Morphological characterization of cdkl5 homozygous mutant was also evaluated at an older stage of development (Fig. 3A). Similarly, homozygous mutant larvae at 14 dpf continued to show smaller total body length and displayed reduced head length, anterior head width and posterior head width compared to wild-type larvae (Fig. 3B). These results suggest a microcephaly phenotype, similarly to a known characteristic of CDKL5 deficiency disorder in humans14.
Skeletal development of cdkl5 sa21938 mutant zebrafish
CDKL5 has been suggested to play a role in bone metabolism2,15. To investigate the consequence of Cdkl5 loss-of-function in craniofacial and axial skeleton development, cdkl5sa21938 mutant and WT zebrafish with 5 dpf and 14 dpf were double-stained with alcian blue to visualize the cartilage and alizarin red to visualize calcified bone structures. At 5 dpf, all craniofacial cartilage structures were visible and there were no evident morphology differences between WT and cdkl5 heterozygous mutant embryos. However, homozygous mutant embryos displayed an altered craniofacial morphology (Fig. 4A). The craniofacial cartilage structures were evaluated by measuring the ceratohyal angle (Ch-a), ceratohyal length (Ch-l), palatoquadrate length (Pq-l), ceratohyal cartilage length (CCL), and lower jaw length (LJL) (Fig. 4B). Both heterozygous and homozygous mutant embryos displayed a significantly reduced CCL and LJL, being more pronounced in the cdkl5−/− embryos. Additionally, cdkl5−/− embryos also showed a significantly shorter Ch-l and Pq-l compared to cdkl5+/− and WT embryos (Fig. 4C). The ceratohyal angle was significantly increased in the cdkl5−/− embryos. Mineralized bone formation stained in red showed no abnormalities in 5 dpf cdkl5 mutants compared to WT embryos. These data suggest that cdkl5 homozygous mutant zebrafish present an abnormal cartilage development.
At 14 dpf, our results showed that the level of mineralized areas in homozygous cdkl5 mutants stained with alizarin red was decreased compared to the WT larvae (Fig. 5A). During this stage of development, the number of mineralized vertebrae in cdkl5−/− larvae was significantly lower than WT (Fig. 5B) and mainly found in the anterior part of the axial skeleton. The mineralized caudal fin rays were also significantly lower in cdkl5−/− compared to the WT larvae, with only 5% of the homozygous mutant larvae presenting mineralized rays in the caudal fin (Fig. 5C). These results suggest an impairment or delay of bone mineralization in cdkl5 mutants.
Motor behavior of cdkl5 sa21938 mutant zebrafish
One of the main characteristics of CDKL5 deficiency disorder is the impairment of motor skills, such as the limited ability to walk. Therefore, we analyzed the locomotor behavior of cdkl5sa21938 mutant embryos.
The first motor activity of embryonic zebrafish is the spontaneous coiling which can be classified into two groups: single coiling and double coiling. Single coiling consists of a single contraction of the trunk, after which the tail returned to its resting position. While double coiling consists of two contralateral contractions of the trunk within 1 s. Between these two contractions, the tail does not return to a resting position16. Spontaneous contractions of 25 hpf dechorionated embryos were monitored. Our results showed no significant differences in the number of spontaneous coiling per minute between the cdkl5+/−, cdkl5−/− and wild-type embryos. However, mutant embryos presented less percentage of double coiling compared to the wild-type embryos, being this decrease more pronounced in the homozygous embryos (Fig. 6A). The arising of double coiling represents an event in the stepwise maturation from a single coiling behavior to swimming. While single coiling is independent of chemical neurotransmission, double coiling is dependent on both electrical and glutamatergic transmission16. Therefore, results suggest that the glutamatergic transmission of cdkl5sa21938 mutants may be impaired or delayed.
The spontaneous swimming behavior of mutant and wild-type embryos at 5 dpf was also monitored for 5 min in a 24-well plate. The distance travelled by the cdkl5−/− mutant embryos was significantly decreased compared to the cdkl5+/− and wild-type embryos, suggesting an impaired locomotor activity (Fig. 6B). The thigmotaxis i.e., the tendency to avoid the center of an arena and swim close to the borders of the well, was also analyzed. cdkl5−/− embryos spent slightly but significantly more time in the inner region of the well compared to the cdkl5+/− and WT embryos (Fig. 6C), suggesting a reduced thigmotactic behavior.
To investigate the response to PTZ, a seizure-inducing drug that is a GABA receptor inhibitor17, WT and cdkl5sa21938 mutant embryos at 5 dpf were exposed to 16 mM of PTZ. A seizure-like behavior such as rush, circular swimming motion followed by a series of brief clonus-like convulsions18 was observed in WT, cdkl5+/− and cdkl5−/− embryos. The three groups of embryos also presented a significant increase in the distance travelled. However, that increase was significantly greater in the homozygous mutants compared to the wild-type fish thus indicating higher susceptibility to seizures. The spontaneous and PTZ induced locomotor trajectories of WT, cdkl5+/− and cdkl5−/− embryos are represented in Fig. 6D.
Molecular analysis of cdkl5 sa21938 mutant zebrafish
To investigate the molecular pathways affected by a loss of Cdkl5 function in zebrafish, gene expression analysis of several neuronal associated genes known to be related to CDKL5 or Rett syndrome was performed by qPCR in WT, cdkl5+/− and cdkl5−/− mutant embryos at 5 dpf. Our results showed alterations in the expression of the analyzed neuronal markers. The methyl CpG binding protein 2 (MECP2), associated with Rett syndrome, is a chromatin-associated protein that binds to methylated CpG sites of genes, regulating their activity19. It was demonstrated that MECP2 represses CDKL5 transcription and that CDKL5 can phosphorylate MECP220. MECP2 is also known to affect the activity of BDNF (Brain-derived neurotrophic factor) which is an important regulator of neuronal development and function21,22. Interestingly, studies showed that CDKL5 regulates neuronal morphogenesis through a mechanism involving BDNF-Rac1 signaling6. In our study, levels of bdnf and mecp2 were equally significantly increased in cdkl5 heterozygous and homozygous mutant embryos compared to the WT embryos (Fig. 7A), indicating dysregulation of these pathways due to Cdkl5 loss-of-function. BDNF was shown to activate several members of the myocyte enhancer factor 2 (MEF2) family of transcription factors23. MEF2C mutations cause severe mental retardation with phenotypical overlap to Rett syndrome and can significantly reduce MECP2 and CDKL5 expression24. The expression of Dopamine Receptor D2 (Drd2), a major mediator of dopamine effects with diverse functions such as cognition, movement, learning and memory, was found increased in the striatum of Mecp2 mutant mice25. Our results showed that levels of mef2ca and drd2a were also significantly increased but only in the homozygous embryos (Fig. 7A).
Since impairment of the glutamatergic neurotransmission in cdkl5sa21938 mutants was suggested by our spontaneous motor behavior results, the expression of glutamatergic genes was also evaluated. We analyzed the expression of different types of glutamate receptors, namely the ionotropic NMDA receptor grin1b, the ionotropic AMPA receptor grin2a, the metabotropic receptor grm1b, and the glutamate transporter slc1a1. Levels of grin1b were significantly increased in the cdkl5−/− mutant embryos compared to WT embryos. Levels of grm1b, and slc1a1 were increased in cdkl5+/− and cdkl5−/− mutant embryos (Fig. 7B). Although an increase in the expression of gria2b was observed, no statistically significant differences were found between WT and cdkl5sa21938 mutant embryos (Fig. 7B).
CDKL5 deficiency disorder is a drug-resistant epileptic encephalopathy and currently no approved therapies are available for its treatment26. Several mouse models have been developed to gain insights into the molecular changes underlying CDD and to develop new treatments27,28,29,30. Zebrafish is a suitable biomedical model and shares many physiological processes with humans11. Additionally, it offers important advantages over other models that could be relevant to study CDD, such as translucent embryos and larvae, allowing the visualization of organs during early development, and easy access for genetic manipulation. Furthermore, it is also well suited to high-throughput drug screening31,32,33,34. In our study, we characterized the morphology, motor behavior, and molecular changes of the cdkl5sa21938 zebrafish mutant line at its initial developmental stages. ENU-mutagenesis can originate other mutations along with the desired mutation. To exclude the possible effect of undesired mutations our experiments were performed using fish generated from several outcrosses.
cdkl5sa21938 mutant zebrafish did not show an obvious phenotype, however detailed morphological analysis revealed a reduced head size already apparent in heterozygous but more pronounced in homozygous mutants in comparison with the wild-type. Our results suggest that Cdkl5 loss-of-function leads to a microcephaly phenotype in zebrafish, a feature frequently observed in patients with CDKL5 deficiency disorder14. Our results are in agreement with the recently published data by Serrano et al. who also showed the presence of a microcephaly phenotype in this mutant35. Further studies could be performed to confirm this observation, such as sections of the head to visualize brain size.
CDKL5 has been suggested to have a potential role in bone metabolism. A recent study showed that it was hypermethylated in all the osteoporotic participants15. Furthermore, scoliosis and several dysmorphic facial features such as midface hypoplasia, high forehead, large and deep-set eyes, full lips, high palate, and widely spaced teeth have been identified in individuals diagnosed with CDD2. Since zebrafish is considered a robust model for the craniofacial abnormalities observed in humans36, we investigated the Cdkl5 loss-of-function effect in embryos and larvae craniofacial and skeletal development. The cdkl5 homozygous mutants presented mild cartilage development defects, such as hypoplasia of palatoquadrates and ceratohyals cartilages and wider ceratohyal angle, which may correlate with the phenotype observed in individuals with CDD. To shed light on the observed changes, the expression levels of genes related to cartilage should be performed. Accordingly, a significant decrease in the ceratohyal cartilage distance was also described by Serrano et al. However, they observed a decrease in the ceratohyal angle35, contrary to what was observed in our study. This discrepancy could be due to the low number of fish analyzed (n = 13) in their study. In our study, an overall decrease in bone mineralization was observed in homozygous cdkl5 mutants in comparison to wild-type larvae at 14 dpf. Altogether, these results indicate that Cdkl5 is needed for both normal cartilage craniofacial development and skeletal development. The presence of skeletal deformities in adult mutant fish should be evaluated to further elucidate the Cdkl5 role in bone formation.
Motor dysfunction is a prominent feature of CDKL5 deficiency disorder. Since zebrafish is recognized as a valuable model to study genetically linked motor defects and behaviors observed in neurodevelopmental human diseases37, the motor behavior of cdkl5sa21938 mutants was investigated. No differences were observed in the frequency of spontaneous single contractions, that is the earliest embryonic motor behavior, between cdkl5sa21938 mutants and wild-type embryos. Spontaneous coiling is driven by excitatory activity in the spinal cord and it is only dependent on the electrical coupling of the neuronal network. Subsequently, as chemical neurotransmission develops, mature locomotion is achieved16. Our results indicate that excitation in the spinal cord is not affected by Cdkl5 loss-of-function. The double coiling represents a transition behavior between single coiling and swimming activity driven by chemical glutamatergic and glycinergic neurotransmission16. cdkl5sa21938 embryos showed a reduced percentage of double coiling suggesting that Cdkl5 deficiency results in abnormal glutamatergic neurotransmission. Locomotor behavior analysis revealed that the swimming activity was reduced in cdkl5 homozygous embryos, which covered a shorter swimming distance. Accordingly, a significant decrease in distance swum by the homozygous mutant was also reported by Serrano et al.35. The available works using CDKL5 KO mice showed contradictory behavioral results among them, with both hypoactivity and hyperactivity reported in these studies27,28,29,38. Altogether, these results suggest that Cdkl5 ablation in zebrafish causes impairment in their motor activity, following what was observed in individuals with CCD that have impaired motor skills such as delayed or impaired walking.
The thigmotaxis behavior used to evaluate the level of anxiety was also investigated. Homozygous cdkl5 embryos showed a slight but significant reduced thigmotaxis. These results may suggest that embryos with defective Cdkl5 have anxiety behavioral alterations or could be sensitive to the tactile stimuli represented by the wall of the well, a behavior that resembles the autistic features in CDD individuals. In accordance, Wang et al. reported a decreased anxiety-related behavior and autistic-like behavior in Cdkl5 KO mice30.
Although early-onset seizures are a central characteristic of CDKL5 deficiency disorder, spontaneous seizures were not apparent in cdkl5sa21938 zebrafish embryos, at least through the analysis of the mutant fish swimming behavior with the tested conditions (5 min of tracking and 5 dpf zebrafish). Nevertheless, we cannot affirm that the cdkl5sa21938 mutant does not have spontaneous seizures. The absence of spontaneous seizures could be simply because of the parameters used, such as the age of the fish and the time of tracking used for the analysis. Thus, the behavior of mutants at older stages of development should be further analyzed, and the time of tracking could be increased. Electroencephalographic records should also be performed to investigate the epileptic phenotype. Interestingly, Serrano et al. identified the existence of spontaneous seizures in cdkl5 zebrafish mutants through live imaging of the brain by using a transgenic line expressing a genetically-encoded calcium indicator. This represents an advantage over the existent Cdkl5 mouse models that do not exhibit spontaneous seizures at initial developmental stages27,29,30. Nevertheless, our results showed that after treatment with a seizure-inducing drug, a seizure behavior was achieved by the homozygous fish, with an increase in their swimming activity. And that increase was significantly greater in the homozygous mutants compared to the wild-type fish thus, indicating higher susceptibility to seizures. This could be valuable to identify epileptic mechanisms affected by Cdkl5 loss-of-function in CDD. The latency, number of seizures, seizure times and the interval between seizures should also be investigated to better characterize the epileptic events.
To shed light on the molecular pathways affected by defective Cdkl5, the expression levels of brain-related genes were examined in the mutant cdkl5sa21938 embryos. The genes bdnf, mecp2 mef2ca and drd2a were upregulated in homozygous embryos. BDNF is crucial for the central nervous system development, and studies show that it is involved in epileptogenesis. Although there are contradictory data, some studies indicate that higher levels of BDNF induce epilepsy39. MECP2 is a methyl-CpG-binding protein important for appropriate neuronal development. In vivo studies showed that mice overexpressing MECP2 develop seizures and are less active40, therefore the presence of higher levels of this gene in mutant embryos provides further evidence for the presence of abnormal neuronal development/function. Since our results suggested an impairment of the glutamatergic neurotransmission in the cdkl5sa21938 mutants, we also analyzed the expression of glutamatergic-related genes, including the NMDA receptor grin1b, the AMPA receptor grin2a, the metabotropic receptor grm1b, and the glutamate transporter slc1a1. These genes were all overexpressed in the cdkl5sa21938 mutants, confirming that the glutamatergic pathway is affected. The connection between the dysregulation of expression of the analyzed genes and the observed phenotype should be further investigated, and the expression of additional genes should be analyzed to identify the molecular basis of the disease, for instance by performing RNA-seq.
In conclusion, our data show that homozygous cdkl5sa21938 zebrafish recapitulate a number of characteristics of CDKL5 deficiency disorder, such as the presence of microcephaly, craniofacial dysmorphic features, and locomotor behavior defects. Therefore, this work provides evidence that validates the use of this model organism to further study CDKL5 function and associated molecular pathways, in order to better understand the physiopathology of CDD. Furthermore, it represents a suitable in vivo model for the first-line screening of small-molecule libraries for total/partial rescue of phenotypes mimicking CDKL5 deficiency disorder.
All procedures involving zebrafish experimentation were performed in accordance with the EU and Portuguese legislation for animal experimentation and welfare (Directives 86/609 CEE and 2010/63/EU; Decreto-Lei 113/2013; Portaria1005/92, 466/95 and 1131/97) and in compliance with ARRIVE guidelines (https://arriveguidelines.org). This study was approved by the Portuguese Direção-Geral de Alimentação e Veterinária (authorization no. 0421/2021). Animal handling and experimentation were performed by qualified operators. All efforts were made to minimize pain, distress, and discomfort. Experiments were terminated (fish were returned to normal conditions or euthanized) whenever adverse effects were observed.
Mutant cdkl5sa21938 zebrafish line generated by Stemple lab41 was obtained from EZRC. Adult wild-type (WT) zebrafish (AB strain) and cdkl5sa21938 mutant zebrafish were maintained in a recirculating system at controlled room temperature (28 °C) and kept under a 14 h light -10 h dark cycle. For the reproductions, adult females were separated from males with plastic dividers in breeding boxes the night before spawning. The next day, they were allowed to spawn naturally. The embryos were raised in E3 medium with 0.1% methylene blue to avoid fungal contamination and staged according to the morphological scheme described by Kimmel et al.42. Dead or undeveloped embryos were removed daily. For the experiments using the cdkl5sa21938 mutant line, heterozygous embryos were obtained by crossing adults F3 homozygous mutants with AB wild-type zebrafish; homozygous embryos were obtained by incross adults F3 homozygous mutants, and AB wild-type zebrafish was used as control.
Genotyping of cdkl5 sa21938 zebrafish mutants
To extract genomic DNA (gDNA), adult zebrafish were anesthetized in tricaine methanesulfonate (MS222) solution (168 mg/L), and the tail fin was clipped and incubated at 95 °C in 25 μl alkaline lysis buffer containing 25 mM NaOH and 0.2 mM EDTA. After dissolution, 25 μl of neutralization buffer (40 mM Tris–HCl. pH = 8) was added. Then, the cdkl5 fragment flanking the mutation was amplified by polymerase chain reaction (PCR) from 50 ng of gDNA using specific primers (Table 1) and Taq DNA polymerase (Invitrogen) following manufacturer instructions. PCR conditions were as follows: initial denaturation step at 94 °C for 3 min; 35 cycles of amplification (denaturation at 94 °C for 30 s; annealing at 57 °C for 30 s; extension at 72 °C for 15 s); and a final extension at 72 °C for 10 min. PCR products were separated in an agarose gel (1.2%) by electrophoresis, then visualized under ultraviolet light using Safe Green nucleic acid stain (Nzytech) and sequenced (CCMAR).
Morphometric analysis of cdkl5 mutant line
Phenotype of zebrafish cdkl5 mutants was visualized and photographed at different developmental stages using a Leica MZ10F stereomicroscope. Parameters including body length, head length and head width were measured using ImageJ software.
Alcian blue-Alizarin red double staining
Zebrafish with 5 dpf and 14 dpf were collected and sacrificed with a lethal dose of anesthesia (MS222). After washing twice with phosphate-buffered saline (PBS), zebrafish were fixed overnight in 4% paraformaldehyde (PFA; Sigma). They were washed twice with PBS and dehydrated in increasing ethanol series. Acid-free double staining was performed following Walker and Kimmel protocol43. Briefly, zebrafish were incubated with double stain solution (0.02% Alcian blue, 40 mM MgCl2, 0,005% Alizarin red S) overnight at room temperature under agitation. The pigmentation was removed by exposing the zebrafish to a bleaching solution of 1.5% H2O2 and 1% KOH for 20 min. Then, the tissue was cleared using successive changes of glycerol and KOH solution. Stained zebrafish were visualized and imaged using a stereomicroscope (Leica MZ10F). Several craniofacial parameters, such as ceratohyal angle (Ch-a), ceratohyal length (Ch-l), palatoquadrate length (Pq-l), ceratohyal cartilage length (CCL) and lower jaw length (LJL) were measured using Image J.
The motor behavior of cdkl5 mutant zebrafish was characterized through several parameters and compared to wild-type or control fish. The rate of spontaneous coiling contractions was analyzed at 25 h post-fertilization (hpf). For that, embryos were dechorionated and placed in a 12-well plate filled with 2 ml of water. After 1 h of habituation each fish was recorded for 2 min using a stereomicroscope.
To monitor the spontaneous swimming activity, embryos with 5 days post-fertilization (dpf) were randomly placed in a 24-well plate filled in with 2 ml of water. Homogeneous illumination was provided, and swimming motor behavior was monitored for 5 min using the ZANTIKS apparatus. Parameters such as distance travelled, thigmotaxis and swimming patterns were analyzed. Embryos that did not swim were excluded from the analysis. To investigate thigmotactic behavior, wells were divided into two zones: an inner circular region (radius 4.5 mm) and an outer circular region (radius 8 mm); and the time spent by the embryos in each region was assessed.
Embryos’ behavior was also analyzed after treatment with PTZ, a seizure-inducing drug. For that, the water from each well was removed and 2 ml of PTZ solution (16 mM; Sigma) was added. After 10 min, swimming behavior was recorded for 5 min using the ZANTIKs apparatus.
RNA extraction and cDNA synthesis
Pools of approximately 30 cdkl5sa21938 mutant embryos with 5 dpf were collected, sacrificed with a lethal concentration of anesthesia (MS22), and washed twice with PBS. Total RNA was extracted using NZYol (NZYTech) according to the manufacturer’s instructions and its quality was accessed through electrophoresis in an agarose gel stained with GreenSafe (NZYTech). At least three biological replicates were obtained from individual experiments. For reverse transcription, 1 µg of total RNA was subjected for 30 min at 37 °C to RQ1 RNase-free DNase (Promega) and cDNA was synthesized by the Moloney murine leukemia virus reverse transcriptase (Invitrogen) using an oligo-dT primer.
Quantitative real-time PCR (qPCR)
Amplifications by qPCR were carried out in a total volume of 20 µl, containing 1 × NZYSpeedy qPCR Green Master Mix ROX plus (NZYTech), 0.4 μM of each forward and reverse gene-specific primers and 2 μl of cDNA (1:10 dilution). Gene-specific primers are listed in Table 1. qPCR reactions were performed in a CFX Connect Real-Time PCR Thermocycler (Bio-Rad) under the following conditions: an initial denaturation step at 95 °C for 2 min, then 40 cycles of amplification (each cycle is 5 s at 95 °C, 20 s at 60 °C). Relative gene expression was determined by 2–∆∆Ct and normalized using β-actin as reference gene (Table 1). Two technical replicates for each sample were performed.
Statistical analysis was performed using Prism 5 (GraphPad Software). Data normality was assessed using Kolmogorov–Smirnov test. Normally distributed data are presented as mean ± SD and significant differences were determined through one-way analysis of variance (ANOVA) followed by Tukey’s post-test for three groups and t-test with Welch correction for two groups. Data failing the normality test are presented as median with the interquartile region (boxplot) and significant differences were determined through Kruskal–Wallis followed by Dunn multiple comparisons test for three groups and Mann–Whitney test for two groups. The Chi-square test was used to analyze the occurrence of mineralized caudal fin rays. Differences were considered statistically significant for p < 0.05.
The data generated and analyzed during this study are available from the corresponding author upon reasonable request.
Bahi-Buisson, N. et al. Key clinical features to identify girls with CDKL5 mutations. Brain 131, 2647–2661. https://doi.org/10.1093/brain/awn197 (2008).
Fehr, S. et al. The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur. J. Hum. Genet. 21, 266–273. https://doi.org/10.1038/ejhg.2012.156 (2013).
Russo, S. et al. Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. Neurogenetics 10, 241–250. https://doi.org/10.1007/s10048-009-0177-1 (2009).
Rusconi, L. et al. CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J. Biol. Chem. 283, 30101–30111. https://doi.org/10.1074/jbc.M804613200 (2008).
Sekiguchi, M. et al. Identification of amphiphysin 1 as an endogenous substrate for CDKL5, a protein kinase associated with X-linked neurodevelopmental disorder. Arch. Biochem. Biophys. 535, 257–267. https://doi.org/10.1016/j.abb.2013.04.012 (2013).
Chen, Q. et al. CDKL5, a protein associated with Rett syndrome, regulates neuronal morphogenesis via Rac1 signaling. J. Neurosci. 30, 12777–12786. https://doi.org/10.1523/JNEUROSCI.1102-10.2010 (2010).
Nawaz, M. S. et al. CDKL5 and shootin1 interact and concur in regulating neuronal polarization. PLoS ONE https://doi.org/10.1371/journal.pone.0148634 (2016).
Zhu, Y. C. & Xiong, Z. Q. Molecular and synaptic bases of CDKL5 disorder. Dev. Neurobiol. 79, 8–19. https://doi.org/10.1002/dneu.22639 (2019).
Kundap, U. P., Kumari, Y., Othman, I. & Shaikh, M. F. Zebrafish as a model for epilepsy-induced cognitive dysfunction: A pharmacological, biochemical and behavioral approach. Front. Pharmacol. 8, 1–13. https://doi.org/10.3389/fphar.2017.00515 (2017).
Mullins, M. C., Acedo, J. N., Priya, R., Solnica-Krezel, L. & Wilson, S. W. The zebrafish issue: 25 years on. Development https://doi.org/10.1242/dev.200343 (2021).
Choi, T. Y., Choi, T. I., Lee, Y. R., Choe, S. K. & Kim, C. H. Zebrafish as an animal model for biomedical research. Exp. Mol. Med. 53, 310–317. https://doi.org/10.1038/s12276-021-00571-5 (2021).
Katayama, S. et al. Expression analyses of splice variants of zebrafish cyclin-dependent kinase-like 5 and its substrate, amphiphysin 1. Gene 583, 15–23. https://doi.org/10.1016/j.gene.2016.02.036 (2016).
Vitorino, M., Cunha, N., Conceição, N. & Cancela, M. L. Expression pattern of cdkl5 during zebrafish early development: Implications for use as model for atypical Rett syndrome. Mol. Biol. Rep. 45, 445–451. https://doi.org/10.1007/s11033-018-4180-1 (2018).
Bahi-Buisson, N. et al. Recurrent mutations in the CDKL5 gene: Genotype-phenotype relationships. Am. J. Med. Genet. Part A 158A, 1612–1619. https://doi.org/10.1002/ajmg.a.35401 (2012).
Cheishvili, D. et al. Identification of an epigenetic signature of osteoporosis in blood DNA of postmenopausal women. J. Bone Miner. Res. 33, 1980–1989. https://doi.org/10.1002/jbmr.3527 (2018).
Knogler, L. D., Ryan, J., Saint-Amant, L. & Drapeau, P. A hybrid electrical/chemical circuit in the spinal cord generates a transient embryonic motor behavior. J. Neurosci. 34, 9644–9655. https://doi.org/10.1523/JNEUROSCI.1225-14.2014 (2014).
Samokhina, E. & Samokhin, A. Neuropathological profile of the pentylenetetrazol (PTZ) kindling model. Int. J. Neurosci. 128, 1086–1096. https://doi.org/10.1080/00207454.2018.1481064 (2018).
Baraban, S. C., Taylor, M. R., Castro, P. A. & Baier, H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131, 759–768. https://doi.org/10.1016/j.neuroscience.2004.11.031 (2005).
Good, K. V., Vincent, J. B. & Ausió, J. MeCP2: The genetic driver of Rett syndrome epigenetics. Front. Genet. 12, 620859. https://doi.org/10.3389/fgene.2021.620859 (2021).
Mari, F. et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum. Mol. Genet. 14, 1935–1946. https://doi.org/10.1093/hmg/ddi198 (2005).
Miranda, M., Morici, J. F., Zanoni, M. B. & Bekinschtein, P. Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain. Front. Cell. Neurosci. 13, 363. https://doi.org/10.3389/fncel.2019.00363 (2019).
Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255–269. https://doi.org/10.1016/j.neuron.2006.09.037 (2006).
Flavell, S. W. et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311, 1008–1012. https://doi.org/10.1126/science.1122511 (2006).
Zweier, M. et al. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum. Mutat. 31, 722–733. https://doi.org/10.1002/humu.21253 (2010).
Kao, F. C., Su, S. H., Carlson, G. C. & Liao, W. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome. Brain Struct. Funct. 220, 419–434. https://doi.org/10.1007/s00429-013-0664-x (2015).
Jakimiec, M., Paprocka, J. & Śmigiel, R. CDKL5 deficiency disorder—a complex epileptic encephalopathy. Brain Sci. https://doi.org/10.3390/brainsci10020107 (2020).
Amendola, E. et al. Mapping pathological phenotypes in a mouse model of CDKL5 disorder. PLoS ONE https://doi.org/10.1371/journal.pone.0091613 (2014).
Fuchs, C. et al. Heterozygous CDKL5 knockout female mice are a valuable animal model for CDKL5 disorder. Neural Plast. https://doi.org/10.1155/2018/9726950 (2018).
Okuda, K. et al. Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory. PLoS ONE https://doi.org/10.1371/journal.pone.0196587 (2018).
Wang, I. T. J. et al. Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proc. Natl. Acad. Sci. U.S.A. 109, 21516–21521. https://doi.org/10.1073/pnas.1216988110 (2012).
Fontana, B. D., Mezzomo, N. J., Kalueff, A. V. & Rosemberg, D. B. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review. Exp. Neurol. 299, 157–171. https://doi.org/10.1016/j.expneurol.2017.10.004 (2018).
Ali, S., Champagne, D. L., Spaink, H. P. & Richardson, M. K. Zebrafish embryos and larvae: A new generation of disease models and drug screens. Birth Defects Res. Part C Embryo Today Rev. 93, 115–133. https://doi.org/10.1002/bdrc.20206 (2011).
Lessman, C. A. The developing zebrafish (Danio rerio): A vertebrate model for high-throughput screening of chemical libraries. Birth Defects Res. Part C Embryo Today Rev. 93, 268–280. https://doi.org/10.1002/bdrc.20212 (2011).
Aleström, P., Holter, J. L. & Nourizadeh-Lillabadi, R. Zebrafish in functional genomics and aquatic biomedicine. Trends Biotechnol. 24, 15–21. https://doi.org/10.1016/j.tibtech.2005.11.004 (2006).
Serrano, R. J. et al. Novel pre-clinical model for CDKL5 Deficiency Disorder. Dis Mod Mech https://doi.org/10.1242/dmm.049094 (2021).
Raterman, S. T., Metz, J. R., Wagener, F. A. D. T. G. & von den Hoff, J. W. Zebrafish models of craniofacial malformations: Interactions of environmental factors. Front. Cell Dev. Biol. 8, 600926. https://doi.org/10.3389/fcell.2020.600926 (2020).
Sakai, C., Ijaz, S. & Hoffman, E. J. Zebrafish models of neurodevelopmental disorders: Past, present, and future. Front. Mol. Neurosci. 11, 294. https://doi.org/10.3389/fnmol.2018.00294 (2018).
Jhang, C. L., Huang, T. N., Hsueh, Y. P. & Liao, W. Mice lacking cyclin-dependent kinase-like 5 manifest autistic and ADHD-like behaviors. Hum. Mol. Genet. 26, 3922–3934. https://doi.org/10.1093/hmg/ddx279 (2017).
Wang, X., Hu, Z. & Zhong, K. The role of brain-derived neurotrophic factor in epileptogenesis: An update. Front. Pharmacol. 12, 758232. https://doi.org/10.3389/fphar.2021.758232 (2021).
Collins, A. L. et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679–2689. https://doi.org/10.1093/hmg/ddh282 (2004).
Busch-Nentwich, E. et al. Sanger Institute Zebrafish Mutation Project mutant data submission. ZFIN Direct Data Submissions (2013).
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253–310. https://doi.org/10.1002/aja.1002030302 (1995).
Walker, M. B. & Kimmel, C. B. A two-color acid-free cartilage and bone stain for zebrafish larvae. Biotech. Histochem. 82, 23–28. https://doi.org/10.1080/10520290701333558 (2007).
This study was funded by the Million Dollar Bike Grant program from the Orphan Disease Center, University of Pennsylvania, USA (Award Number: MDBR-19-104-CDKL5) and received national funds from the Portuguese Foundation for Science and Technology (FCT) through the project UIDB/04326/2020 (CCMAR). Tatiana Varela, Débora Varela and Gil Martins are recipients of a Ph.D. fellowship from FCT (SFRH/BD/144230/2019; SFRH/BD/141918/2018 and SFRH/BD/1463378/2019, respectively). Authors acknowledge Marco Tarasco for sharing the macro used for the embryos locomotive trajectory. They also acknowledge Câmara Municipal de Loulé for the support provided.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Varela, T., Varela, D., Martins, G. et al. Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder. Sci Rep 12, 9325 (2022). https://doi.org/10.1038/s41598-022-13364-1